Biologia da mucosa gástrica e comportamento de ingesta de ratos Wistar, submetidos à administração oral de etoricoxib
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Non steroidal anti-inflammatory are drugs used to treat and control many diseases,
on all mammary species. Many studies have been developed on animals and humans to observe
the effects of this group of drugs on gastrointestinal tract mucosa. Gastric and duodenal lesions
are among the side effects caused by non selective cyclooxygenase suppression. Etoricoxib is a
new non steroidal anti-inflammatory drug, highly selective cyclooxygenase 2 inhibitor, that
preserves gastric and duodenal mucosa protective function. The objective of this work was to
study the biological effect of Etoricoxib oral administration, on rats gastric and duodenal mucosa,
food and water ingestion and body weight changes. Forty five Wistar rats were divided on 3
groups. The first one (control group) received 0.9% Sodium chloride solution, The second and
third one received 0.5 and 5.0 mg/day Etoricoxib, respectively. During 10 days period, food,
water and body weight were measured. All animals were anesthetized and killed on the 11th day.
Stomach and duodenum were macro and microscopically evaluated. We concluded that there was
no significant difference on body weight changes, nor water or food ingestion on any studied
groups. Enantema, erosions or ulcers were not observed macro or microscopically. Soft and
diffuse eosinophilic infiltrate was observed on both treated groups. Soft submucosa
linphoplasmocitary infiltrate was observed on the higher dose Etoricoxib group (5.0 mg/day).
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
